Showing posts with label formulation of dihydroergotamine (see above structure. Show all posts
Showing posts with label formulation of dihydroergotamine (see above structure. Show all posts
Friday, May 27, 2011

MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults

›
Levadex is designed to be differentiated from existing migraine treatments. It is a novel formulation of dihydroergotamine (see above...